ES2165020T3 - Monohidrato de famciclovir. - Google Patents

Monohidrato de famciclovir.

Info

Publication number
ES2165020T3
ES2165020T3 ES97902336T ES97902336T ES2165020T3 ES 2165020 T3 ES2165020 T3 ES 2165020T3 ES 97902336 T ES97902336 T ES 97902336T ES 97902336 T ES97902336 T ES 97902336T ES 2165020 T3 ES2165020 T3 ES 2165020T3
Authority
ES
Spain
Prior art keywords
monohidrate
famciclovir
pharmaceutical use
pharmaceutical
famciclovir monohidrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97902336T
Other languages
English (en)
Inventor
Kenneth C Campbell
Michael John Greenway
Stephen A Hancock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602403.9A external-priority patent/GB9602403D0/en
Priority claimed from GBGB9618494.0A external-priority patent/GB9618494D0/en
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of ES2165020T3 publication Critical patent/ES2165020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MONOHIDRATO DE FAMCICLOVIR Y SU USO FARMACEUTICO.
ES97902336T 1996-02-07 1997-02-04 Monohidrato de famciclovir. Expired - Lifetime ES2165020T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602403.9A GB9602403D0 (en) 1996-02-07 1996-02-07 Pharmaceuticals
GBGB9618494.0A GB9618494D0 (en) 1996-09-05 1996-09-05 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2165020T3 true ES2165020T3 (es) 2002-03-01

Family

ID=26308618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97902336T Expired - Lifetime ES2165020T3 (es) 1996-02-07 1997-02-04 Monohidrato de famciclovir.

Country Status (8)

Country Link
EP (1) EP0885223B1 (es)
JP (1) JP4183750B2 (es)
AR (1) AR005730A1 (es)
AU (1) AU1601397A (es)
DE (1) DE69706833T2 (es)
ES (1) ES2165020T3 (es)
HK (1) HK1016590A1 (es)
WO (1) WO1997029108A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2496684A1 (en) * 2002-08-26 2004-03-04 Teva Pharmaceutical Industries Ltd Crystalline solid famciclovir forms i, ii, iii and preparation thereof
CN100369913C (zh) * 2002-08-26 2008-02-20 特瓦制药工业有限公司 Ⅰ晶型、ⅱ晶型、ⅲ晶型泛昔洛韦及其制备方法
JP4731121B2 (ja) * 2004-02-02 2011-07-20 協和発酵キリン株式会社 キサンチン誘導体水和物
US7473780B2 (en) 2004-05-18 2009-01-06 Teva Pharmeceutical Industries Ltd. Drying process for preparing crystalline solid famciclovir

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.

Also Published As

Publication number Publication date
DE69706833T2 (de) 2002-04-11
HK1016590A1 (en) 1999-11-05
AR005730A1 (es) 1999-07-14
EP0885223B1 (en) 2001-09-19
AU1601397A (en) 1997-08-28
WO1997029108A1 (en) 1997-08-14
DE69706833D1 (de) 2001-10-25
EP0885223A1 (en) 1998-12-23
JP4183750B2 (ja) 2008-11-19
JP2000504679A (ja) 2000-04-18

Similar Documents

Publication Publication Date Title
BR9703788A (pt) Sulfonamidas e seu uso
YU15299A (sh) Farmaceutski sastavi
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
BR9708902A (pt) Derivados de benzofurila e seu uso
BR9711586A (pt) Compostos e uso dos mesmo
BR9707812A (pt) Composto composto farmacêutica e uso do composto
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
BR9707808A (pt) Composto composição farmacêutica e uso do composto
BR9703378A (pt) Compostos de estilbeno e seu uso
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
BR9709406A (pt) Fluorenomas alquiloxiamino substituídas e seu uso como inibidores da proteína cinase-c
ES2165020T3 (es) Monohidrato de famciclovir.
IT1288298B1 (it) Sedia scolastica e banco scolastico
NO315610B3 (no) Azolotriaziner og -pyrimidiner
NL1007839A1 (nl) Formulering en gebruik.
MX9200706A (es) Composicion y uso.
DE69720413D1 (de) Adapteranordnung
DE69714215T2 (de) Tabletten mit hohem gehalt an famciclovir
MX18585A (es) Compuestos de pirrol y su uso.
AT995U3 (de) Schülersessel
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
KR970053863U (ko) 콤파스기능을 갖는 자
DE29711731U1 (de) Verkettete Schreibtischanordnung
KR970004037U (ko) 학생용 책상
DE29617914U1 (de) Stehpult

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 885223

Country of ref document: ES